Loading your page…
Marketing-authorisation holder · Spain
4 medicines in 1 country, as authorisation holder and marketer.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine in the registers under its name, current ones first.
4 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| EVICEL SOLUCIONES PARA ADHESIVO TISULAR50-90 mg/ml + 800-1,200 UI/ml · Solución para adhesivo tisular | Human fibrinogen, Human thrombin | Spain | Authorised | 2016 |
| EVARREST MATRIZ ADHESIVA8,6 mg + 37,5 UI · Matriz adhesiva | Human fibrinogen, Human thrombin | Spain | Withdrawn | 2013 |
| EVICEL SOLUCIONES PARA ADHESIVO TISULAR140 mg + 2000 UI · Solución para adhesivo tisular | Proteina plasmatica humana, Human thrombin | Spain | Suspended | 2009 |
| EVICEL SOLUCIONES PARA ADHESIVO TISULAR3,5 mg + 5000 UI · Solución para adhesivo tisular | Proteina plasmatica humana, Human thrombin | Spain | Suspended | 2009 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 4 | 1 | 3 | CompaniesAll medicines |
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.
